CME Group (CME) Stock
NASDAQ · CME
264.78
Fundamentals
Market cap
$95.10B
Price / Earnings ratio
22.7x
Price / Sales ratio
14.3x
Price / Book ratio
3.6x
Return on assets
2.0%
Ex-Dividend date
9 Sep 2026
Last payment date
25 Sep 2026
Dividend amount
$1.30
Dividend yield
4.27%
Debt / Equity ratio
N/A
Recent news

24/7 Wall Street
BitMEX Has Shut Down: Where Do Its Traders Go Now?
NeutralCMESeptember 23, 2026
24/7 Wall StreetNeutral
BitMEX Has Shut Down: Where Do Its Traders Go Now?
CME

Zacks Investment Research
CME Group Expands Equity Derivatives With New Factor Futures
NeutralCMESeptember 22, 2026
Zacks Investment ResearchNeutral
CME Group Expands Equity Derivatives With New Factor Futures
CME

MarketBeat
Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
NeutralCMESeptember 19, 2026
MarketBeatNeutral
Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
CME

Zacks Investment Research
CME Group Rises 5.8% in a Year: How Should You Play the Stock?
NeutralCMESeptember 16, 2026
Zacks Investment ResearchNeutral
CME Group Rises 5.8% in a Year: How Should You Play the Stock?
CME
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell2
Neutral3
Buy4
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2021
2022
2023
2025
8B5B3B0
Debt & Balance Sheet
Total assets
Total liabilities
2021
2022
2023
2025
238B157B79B0
Revenue to Profit
2025$6.5B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$4.0B
Net incomeEarnings
EPS forecast
Actual EPS
$2.96
$2.95
Q2FY25
$2.68
$2.63
Q3FY25
$2.69
Q4FY25
$2.89
Q1FY26
$2.98
Q2FY26
The market is expecting earnings per share of $2.98 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

24/7 Wall Street
BitMEX Has Shut Down: Where Do Its Traders Go Now?
NeutralCMESeptember 23, 2026
24/7 Wall StreetNeutral
BitMEX Has Shut Down: Where Do Its Traders Go Now?
CME

Zacks Investment Research
CME Group Expands Equity Derivatives With New Factor Futures
NeutralCMESeptember 22, 2026
Zacks Investment ResearchNeutral
CME Group Expands Equity Derivatives With New Factor Futures
CME

MarketBeat
Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
NeutralCMESeptember 19, 2026
MarketBeatNeutral
Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
CME

Zacks Investment Research
CME Group Rises 5.8% in a Year: How Should You Play the Stock?
NeutralCMESeptember 16, 2026
Zacks Investment ResearchNeutral
CME Group Rises 5.8% in a Year: How Should You Play the Stock?
CME

The Motley Fool
CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?
NeutralCMESeptember 16, 2026
The Motley FoolNeutral
CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?
CME

Stocktwits
CME Group Names Jack Tobin As Next CFO Ahead Of March 2027 Leadership Transition
NeutralCMESeptember 9, 2026
StocktwitsNeutral
CME Group Names Jack Tobin As Next CFO Ahead Of March 2027 Leadership Transition
CME

Reuters
CME Group names Jack Tobin as CFO
NeutralCMESeptember 9, 2026
ReutersNeutral
CME Group names Jack Tobin as CFO
CME

Schwab Network
Options Trades in CME & MRVL as NVDA Lifts Tech Sector
NeutralCMEAugust 27, 2026
Schwab NetworkNeutral
Options Trades in CME & MRVL as NVDA Lifts Tech Sector
CME

Schwab Network
CME on Single Stock Futures Launch, Using NVDA into Earnings
NeutralCMEAugust 25, 2026
Schwab NetworkNeutral
CME on Single Stock Futures Launch, Using NVDA into Earnings
CME

Zacks Investment Research
Why Is CME (CME) Up 6.5% Since Last Earnings Report?
NeutralCMEAugust 21, 2026
Zacks Investment ResearchNeutral
Why Is CME (CME) Up 6.5% Since Last Earnings Report?
CME
About CME Group
As the world's leading and most diverse derivatives marketplace, CME Group is where the world comes to manage risk. Comprised of four exchanges - CME, CBOT, NYMEX and COMEX - we offer the widest range of global benchmark products across all major asset classes, helping businesses everywhere mitigate the myriad of risks they face in today's uncertain global economy.
SectorFinancial Services
IndustryFinancial Data & Stock Exchanges
Employees3,875
CEOMr. Terrence A. Duffy
IPO DateDec 6, 2002
HeadquartersChicago, IL
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Terrence A. Duffy | Chairman & CEO | 1958 |
| Ms. Lynne C. Fitzpatrick | Senior MD, President & CFO | 1978 |
| Mr. Sunil Cutinho | Chief Information Officer | 1972 |
| Mr. Derek L. Sammann | Senior MD & Global Head of Commodities Markets | 1968 |
| Ms. Julie M. Winkler | Senior MD & Chief Commercial Officer | 1975 |
| Ms. Suzanne Sprague | Senior MD, Group COO & Global Head of Clearing | — |
| Mr. Jack Tobin | MD & Chief Accounting Officer | 1964 |
| Adam Minick | Investor Contact | — |
| Mr. Jonathan L. Marcus J.D. | Senior MD & General Counsel | — |
| Ms. Anita Liskey | Senior Managing Director of Corporate Marketing & Communications | 1965 |
Fundamentals
Valuation
Market cap$95.10B
Price-to-sales ratio14.28
Price-to-book value3.65
Price-earnings ratio22.70
Return on Equity15.00%
Return on Sales85.00%
Return on Assets2.00%
PEG ratio4.71
Earnings Per Share
Earnings Per Share$11.88
Income Statement
Average volume1,891,611
EBITDA$6.08B
1 year high (52w)$329.16
1 year low (52w)$218.31
Dividend
Ex dividend date9 Sep 2026
Dividend amount$1.30
Dividend yield4.27%
Last payment date25 Sep 2026
Dividend yield (TTM)4.27%
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsSell5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
9 Wall Street Analyst Ratings
BUY
44% Buy
33% Hold
22% Sell
Target price
$279.67
Est return
5.74%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -1.4 | +12.2 | +1.0 | +3.8 | ||||||||
| 2022 | +1.8 | +1.9 | +1.9 | -8.5 | -8.3 | +2.7 | -2.3 | -0.1 | -11.2 | -2.7 | +1.7 | -5.5 |
| 2023 | +4.6 | +5.6 | +4.0 | -2.4 | -4.2 | +2.9 | +6.9 | +1.4 | -1.3 | +6.7 | +3.5 | -4.1 |
| 2024 | -1.6 | +7.1 | -1.8 | -1.1 | -2.4 | -2.6 | -0.9 | +9.9 | +3.8 | +0.0 | +6.4 | -1.4 |
| 2025 | +1.6 | +5.5 | +3.3 | +5.7 | +4.3 | -5.2 | +1.0 | -5.1 | +1.8 | -0.1 | +6.5 | -2.1 |
| 2026 | +7.2 | +9.9 | -9.5 | -3.1 | -5.5 | -14.3 | +15.9 | +7.3 | -7.7 |
Corporate actions
Upcoming
No upcoming corporate actions for CME
Past
DividendQ3/26
Ex-dividend date9 Sep 2026
Payable date25 Sep 2026
Amount per share$1.30
DividendQ2/26
Ex-dividend date9 Jun 2026
Payable date25 Jun 2026
Amount per share$1.30
DividendQ1/26
Ex-dividend date10 Mar 2026
Payable date26 Mar 2026
Amount per share$6.15
DividendQ1/26
Ex-dividend date10 Mar 2026
Payable date26 Mar 2026
Amount per share$1.30
DividendQ4/25
Ex-dividend date12 Dec 2025
Payable date30 Dec 2025
Amount per share$1.25
DividendQ3/25
Ex-dividend date9 Sep 2025
Payable date25 Sep 2025
Amount per share$1.25
DividendQ2/25
Ex-dividend date9 Jun 2025
Payable date25 Jun 2025
Amount per share$1.25
DividendQ1/25
Ex-dividend date7 Mar 2025
Payable date26 Mar 2025
Amount per share$1.25
DividendQ4/24
Ex-dividend date9 Dec 2024
Payable date27 Dec 2024
Amount per share$1.15
DividendQ3/24
Ex-dividend date9 Sep 2024
Payable date25 Sep 2024
Amount per share$1.15
DividendQ2/24
Ex-dividend date7 Jun 2024
Payable date25 Jun 2024
Amount per share$1.15
DividendQ1/24
Ex-dividend date7 Mar 2024
Payable date26 Mar 2024
Amount per share$1.15
DividendQ4/23
Ex-dividend date27 Dec 2023
Payable date18 Jan 2024
Amount per share$5.25
DividendQ4/23
Ex-dividend date7 Dec 2023
Payable date28 Dec 2023
Amount per share$1.10
DividendQ3/23
Ex-dividend date7 Sep 2023
Payable date27 Sep 2023
Amount per share$1.10
DividendQ2/23
Ex-dividend date8 Jun 2023
Payable date27 Jun 2023
Amount per share$1.10
DividendQ1/23
Ex-dividend date9 Mar 2023
Payable date27 Mar 2023
Amount per share$1.10
DividendQ4/22
Ex-dividend date27 Dec 2022
Payable date18 Jan 2023
Amount per share$4.50
DividendQ4/22
Ex-dividend date8 Dec 2022
Payable date28 Dec 2022
Amount per share$1.00
DividendQ3/22
Ex-dividend date8 Sep 2022
Payable date27 Sep 2022
Amount per share$1.00
DividendQ2/22
Ex-dividend date9 Jun 2022
Payable date27 Jun 2022
Amount per share$1.00
DividendQ1/22
Ex-dividend date9 Mar 2022
Payable date25 Mar 2022
Amount per share$1.00
DividendQ4/21
Ex-dividend date27 Dec 2021
Payable date14 Jan 2022
Amount per share$3.25
DividendQ4/21
Ex-dividend date9 Dec 2021
Payable date28 Dec 2021
Amount per share$0.90



